Titan Medical Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

3 years ago

TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on the development and commercialization of an…

1933 Industries Reports First Quarter 2022 Financial Results

3 years ago

VANCOUVER, BC / ACCESSWIRE / December 30, 2021 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused…

Trait Biosciences Advances Innovative Water-Soluble Cannabinoid Technology, Delivering Key Milestones in Series A Financing and Appoints Dr. Hanny Kanafani as Vice President

3 years ago

VANCOUVER, BC, Dec. 30, 2021 /PRNewswire/ -- Trait Biosciences Inc., a leading cannabinoid biotechnology research organization, announced that it has…

ResMed Announces Participation in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference

3 years ago

SAN DIEGO, Dec. 30, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer,…

Biofrontera Inc. announces reduction of Biofrontera AG shareholding to less than 50% through warrant exercises

3 years ago

WOBURN, Mass., Dec. 30, 2021 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of…

Madrigal Provides Update on Timeline for Topline Results from the Phase 3 MAESTRO-NAFLD-1 Clinical Trial of Resmetirom

3 years ago

Company now expects to release topline 52-week results from MAESTRO-NAFLD-1 in January 2022CONSHOHOCKEN, Pa., Dec. 30, 2021 (GLOBE NEWSWIRE) --…

LifeMD to Participate in Upcoming January Investor Conferences

3 years ago

NEW YORK, Dec. 30, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (the “Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today…

BeyondSpring Announces Third Quarter 2021 Financial Results and Provides a Corporate Update

3 years ago

- Positive Phase 3 data in 2nd/3rd line NSCLC (Dublin-3): Superior efficacy benefit in plinabulin and docetaxel combination in overall…

Lotus Ventures Inc. Reports Fiscal 2021 Results

3 years ago

VANCOUVER, British Columbia, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Lotus Ventures Inc. (CSE: J) (OTC: LTTSF) (“Lotus” or the “Company”),…

LifeMD to Participate in Panel Presentation at LifeSci Partners Corporate Access Event 2022

3 years ago

CEO Schreiber to discuss changes made possible via proprietary virtual care platformsNEW YORK, Dec. 30, 2021 (GLOBE NEWSWIRE) -- LifeMD,…